(Q41409603)

30 September 2017

1 reference

title

Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen (English)

1 reference

30 September 2017

Dannull J

1

1 reference

30 September 2017

Belldegrun AS

series ordinal

2

1 reference

30 September 2017

publication date

1 March 1997

1 reference

British Journal of Urology

30 September 2017

published in

1 reference

30 September 2017

volume

79 Suppl 1

1 reference

30 September 2017

page(s)

97-103

1 reference

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Gene regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

A tyrosine aminotransferase glucocorticoid response element also mediates androgen enhancement of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5' promoter region of the gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Negative regulation of transcription in eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

Prostate-specific antigen expression is regulated by an upstream enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1997.TB00809.X

10.1111/J.1464-410X.1997.TB00809.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference